台股 » 旭富 » 個股財報 » 報酬率(單一季)
- 股價
97.5
- 漲跌
▼0.5
- 漲幅
-0.51%
- 成交量
274張
- 產業
上市 生技醫療類股
▼0.37%
-
本地時間:13:30
報酬率
ROE(股東權益報酬率) = 淨利÷股東權益。
ROA(資產報酬率) = 淨利÷總資產。
股票投資新手教室：帶您認識資產負債表？
旭富 (4119) 報酬率與季收盤價比較圖
旭富 (4119) 歷年報酬率
| 年度/季別 | ROE | ROA |
| 2024Q3 | 7.28% | 5.42% |
| 2024Q2 | 1.22% | 0.92% |
| 2024Q1 | 0.87% | 0.66% |
| 2023Q4 | -0.08% | -0.06% |
| 2023Q3 | 0.86% | 0.64% |
| 2023Q2 | 5.12% | 3.75% |
| 2023Q1 | 1.73% | 1.25% |
| 2022Q4 | 2.19% | 1.64% |
| 2022Q3 | 1.38% | 1.06% |
| 2022Q2 | 4.07% | 3.13% |
| 2022Q1 | 1.23% | 0.96% |
| 2021Q4 | -0.59% | -0.47% |
| 2021Q3 | 0.89% | 0.70% |
| 2021Q2 | 0.11% | 0.09% |
| 2021Q1 | 1.25% | 0.92% |
| 2020Q4 | -8.02% | -6.32% |
| 2020Q3 | 5.34% | 4.25% |
| 2020Q2 | 6.82% | 5.40% |
| 2020Q1 | 5.85% | 4.97% |
| 2019Q4 | 2.61% | 2.23% |
| 2019Q3 | 4.86% | 3.95% |
| 2019Q2 | 4.81% | 3.89% |
| 2019Q1 | 4.99% | 4.23% |
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨－2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨－2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨－2022/11/23